OMNIlife science

What OMNIlife science does

OMNIlife science is a private medical device company founded in 1999 and headquartered in East Taunton, Massachusetts, with a workforce of 51-100 employees. The aggregated source material describes the company as an orthopaedic technology innovator operating in the robotic-assisted surgery space, anchored by the Apollo platform. The flagship ApolloKnee system combines a pre-resection BalanceBot assessment tool, an AI-assisted surgical planning algorithm, and the Apollo Robot — a compact robotic cutting guide controlled via intraoperative gestures or a draped touchscreen tablet — into a cloud-connected workflow that integrates pre-, intra-, and post-operative data for continuous learning. The portfolio is extended by ApolloHipX, which applies the same connected-technology approach to hip replacement procedures. The platform has received FDA 510(k) clearance, EU MDR approval, and AU TGA registration, supporting a commercial footprint spanning the United States, Europe, and Australia.

The company sells orthopaedic implants combined with robotic and AI-enabled surgical technology to orthopaedic surgeons and healthcare facilities through a B2B2C model. Distribution is organized around a network of 'Centres Of Excellence' and a patient-facing surgeon finder tool that directs patients to credentialed practitioners, with healthcare-professional marketing delivered through the corporate website, resource libraries, industry events, and virtual visitations. Pricing is not publicly disclosed and is consistent with quote-based enterprise sales typical of capital medical equipment. The company has raised approximately $31.5M in disclosed funding across rounds dating back to 2010, with Deerfield as a known institutional investor, and operates with a leadership team that includes a CFO and an SVP of Global Sales, consistent with a commercial-stage medical device business.

Note on source alignment: the aggregated source material predominantly references the 'Corin Group' brand and ApolloKnee/ApolloHipX/BalanceBot/Apollo Robot products, while the firmographics attributes the entity to OMNIlife science (founded 1999, East Taunton, US, 51-100 employees). The description above reflects the technology and product evidence available in the input while honoring the firmographic attribution to OMNIlife science.

Name

OMNIlife science

Legal name

Corin Group

Website

https://omnils.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

51–100 employees

Short description

OMNIlife science designs, manufactures, and distributes orthopaedic implants and robotic-assisted surgery technology, including the ApolloKnee and ApolloHipX platforms, serving orthopaedic surgeons and healthcare facilities with AI-enabled surgical planning and cloud-connected clinical workflows.

Ownership category

akta.pro rank

Product category

Orthopaedic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)

Keywords

• Orthopaedic implants
• Robotic-assisted surgery
• Joint replacement devices
• Surgical robotics
• Orthopaedic medical devices

Headquarters

HQ city

East Taunton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Orthopaedic Implants and Robotics: Sale of clinically proven orthopaedic implants combined with robotic-assisted surgery technology systems. The revenue model combines hardware (implants, robotic equipment) with software (ApolloKnee planning and navigation software) and likely includes service/maintenance components.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

OMNIlife science designs, manufactures, and distributes orthopaedic implants and robotic-assisted surgical technology systems for joint replacement procedures. The company's product portfolio centers on robotic surgery platforms that integrate pre-resection assessment tools, AI-powered surgical planning, robotic cutting guides, and cloud-connected data integration across the surgical workflow for knee and hip replacement.

Product overview

Corin Group offers a unified orthopaedic technology platform centered on Apollo™ robotic-assisted surgery systems. The portfolio includes ApolloKnee™ (robotic knee replacement with BalanceBot™ assessment and Apollo Robot cutting guide) and ApolloHipX™ (hip replacement technology). These products integrate proven implants with cloud-connected robotic and AI solutions for personalized surgical planning, precise implementation, and continuous learning throughout the patient care journey.

Differentiator

Problem solved

Functional benefit

Brands

• ApolloKnee: Robotic-assisted knee surgery system designed to deliver personalized dynamic balance. Combines optimal planning, precise implementation, and continuous learning using BalanceBot pre-resection assessment, Apollo Robot for bone resection, and cloud-computing data integration.
• ApolloHipX

Products and services

• ApolloKnee Robotic-assisted knee replacement system that combines optimal surgical planning, precise robotic bone resection, and continuous cloud-based learning to deliver personalized dynamic balance. Integrates BalanceBot pre-resection assessment, Apollo Robot cutting guide, and AI-powered planning algorithms. Used by orthopaedic surgeons for total knee replacement procedures.
• Apollo Robot Compact robotic cutting guide that ensures precise and efficient bone resection during knee replacement surgery. Controlled via intraoperative gestures or a draped touchscreen tablet. Used as a component of the ApolloKnee surgical workflow.
• BalanceBot Pre-resection knee balance assessment tool that comprehensively evaluates each patient's knee condition prior to bone resection, enabling personalized surgical planning. Used to inform the ApolloKnee AI planning algorithm.
• ApolloHipX Hip replacement technology platform complementing the ApolloKnee offering, providing robotic-assisted capabilities for hip replacement procedures.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Think Surgical: Think Surgical's TSolution One and TMINI robotic systems are active orthopaedic surgical robots for knee replacement targeting a similar surgeon customer base, though with a smaller installed base than the major incumbents.
• Smith+Nephew: Smith+Nephew's CORI surgical robot is a handheld, image-free robotics system for knee arthroplasty, directly competing with ApolloKnee. Smith+Nephew also sells hip implants, overlapping with ApolloHipX.
• Zimmer Biomet: Zimmer Biomet's ROSA Knee and ROSA Hip robotic systems directly compete in robotic-assisted knee and hip replacement, with a deeply entrenched sales force and broad implant portfolio overlapping the ApolloKnee/ApolloHipX offering.
• Stryker: Stryker's Mako robotic-arm assisted surgery platform is the dominant orthopaedic robotics system for knee and hip replacement, directly competing with ApolloKnee and ApolloHipX in the same surgeon and hospital customer base.
• Johnson & Johnson MedTech (DePuy Synthes): Johnson & Johnson's VELYS robotic-assisted solution for knee replacement competes in the same orthopaedic robotics niche, supported by DePuy Synthes' hip and knee implant lines that overlap with the subject's portfolio.

Emerging players

• Brainlab: Brainlab is expanding its orthopaedic footprint with surgical planning and navigation tools, and has entered robotics via partnerships. It addresses a similar surgeon audience in knee and hip workflows but with a more software-and-planning orientation.
• Conformis: Conformis is a smaller orthopaedic implant maker focused on patient-specific knee replacement technology, overlapping the personalized-joint-replacement value proposition that ApolloKnee targets via BalanceBot assessment.

Broad incumbents

• Medtronic: Medtronic operates in surgical robotics broadly (Mazor for spine, Hugo for general surgery) and has expansive orthopaedic relationships, making it a broad incumbent that could enter or expand in joint replacement robotics.
• Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics incumbent (da Vinci) and a benchmark for the surgical robotics business model. While focused on soft-tissue procedures, it represents the platform economics and competitive ceiling relevant to orthopaedic robotics players.
• Exactech: Exactech (now part of TPG-backed entity following 2022 asset purchase) manufactures knee and hip implants competing with the subject's implant portfolio, although it does not currently market a full robotic surgery platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/omni_ortho
• LinkedInlinkedin.com/company/omnilife-science

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OMNIlife science